A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

Recruiting now · Early Phase 1 · Has a placebo group

Conditions studied: Acute Post Operative Pain, Third Molar Extraction Surgery

In brief

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?

Key facts

Study ID

NCT06864884

Run by

Arcato Laboratories, Inc.

People needed

30

Starts

2025-02-26

Expected to finish

2026-02-01

Last updated by the study team

2025-03-11

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to provide informed consent
• In generally good health
• BMI 18 to 38kg/m²
• Scheduled to undergo wisdom teeth extraction

You may not qualify if…

• Serious medical condition
• Clinically significant abnormal lab values
• Blood donation in the last 60 days, or plasma donation in the last 7 days.

Where it is running

• CenExel JBR — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.